Cioffi Christiana Marie 4

What Happened
Cioffi Christiana Marie, Chief Strategy Officer of Fennec Pharmaceuticals (FENC), exercised 4,700 stock options on March 26, 2026, resulting in the acquisition of 4,700 common shares. The exercise price was $4.23 per share, for a total cash outlay of $19,881. The filing shows the related derivative (the option) was disposed (extinguished) as part of the exercise; there is no reported sale of the acquired shares.

Key Details

• Date: 2026-03-26
• Transaction: Option exercise (transaction code M) — 4,700 options exercised to acquire 4,700 shares
• Price per share: $4.23; Total paid: $19,881
• Ownership after transaction: Not reported in this Form 4
• Footnote: Shares acquired through exercise of an option with strike $4.23 and an expiration date of November 13, 2034
• Filing timeliness: Reported on the same date (no late filing indicated)

Context

• This was an exercise of existing stock options (derivative → share conversion), not an open-market purchase or sale. The option instrument was extinguished (reported as a disposed derivative) when the shares were acquired.
• No immediate sale or tax-withholding disposition is reported here; that would typically be shown separately if shares were sold or withheld for taxes.